Join
Live feed
·
PRReleasevia Quantisnow
Intra-Cellular Therapies Inc. logo
Johnson & Johnson logo

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

ByQuantisnow·Wall Street's wire, on your screen.
ITCI· Intra-Cellular Therapies Inc.JNJ· Johnson & Johnson
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITCI (Intra-Cellular Therapies Inc.), JNJ (Johnson & Johnson) and more on Quantisnow.